TSPAN8 As a Novel Emerging Therapeutic Target in Cancer for Monoclonal Antibody Therapy

Overview

Journal Biomolecules

Publisher MDPI

Specialties Biochemistry
Molecular Biology

Date 2020 Mar 7

PMID 32138170

Citations 20

Authors

Kyun Heo

Sukmook Lee

Affiliations

Soon will be listed here.

Abstract

Tetraspanin 8 (TSPAN8) is a member of the tetraspanin superfamily that forms TSPAN8-mediated protein complexes by interacting with themselves and other various cellular signaling molecules. These protein complexes help build tetraspanin-enriched microdomains (TEMs) that efficiently mediate intracellular signal transduction. In physiological conditions, TSPAN8 plays a vital role in the regulation of biological functions, including leukocyte trafficking, angiogenesis and wound repair. Recently, reports have increasingly shown the functional role and clinical relevance of TSPAN8 overexpression in the progression and metastasis of several cancers. In this review, we will highlight the physiological and pathophysiological roles of TSPAN8 in normal and cancer cells. Additionally, we will cover the current status of monoclonal antibodies specifically targeting TSPAN8 and the importance of TSPAN8 as an emerging therapeutic target in cancers for monoclonal antibody therapy.

Citing Articles

New insights into the role of tetraspanin 6, 7, and 8 in physiology and pathology.

Mrozowska M, Gornicki T, Olbromski M, Partynska A, Dziegiel P, Rusak A Cancer Med. 2024; 13(14):e7390.

PMID: 39031113 PMC: 11258570. DOI: 10.1002/cam4.7390.

Migrasome, a migration-dependent organelle.

Zhang F, Liu W, Mao Y, Yang Y, Ling C, Liu Y Front Cell Dev Biol. 2024; 12:1417242.

PMID: 38903534 PMC: 11187097. DOI: 10.3389/fcell.2024.1417242.

Tspan protein family: focusing on the occurrence, progression, and treatment of cancer.

Zhang H, Song Q, Shang K, Li Y, Jiang L, Yang L Cell Death Discov. 2024; 10(1):187.

PMID: 38649381 PMC: 11035590. DOI: 10.1038/s41420-024-01961-0.

Cancer Cell Biomechanical Properties Accompany Tspan8-Dependent Cutaneous Melanoma Invasion.

Runel G, Lopez-Ramirez N, Barbollat-Boutrand L, Cario M, Durand S, Grimont M Cancers (Basel). 2024; 16(4).

PMID: 38398085 PMC: 10887418. DOI: 10.3390/cancers16040694.

Resolving the heterogeneous tumour microenvironment in cardiac myxoma through single-cell and spatial transcriptomics.

Liu X, Shen H, Yu J, Luo F, Li T, Li Q Clin Transl Med. 2024; 14(2):e1581.

PMID: 38318640 PMC: 10844892. DOI: 10.1002/ctm2.1581.

References

Pan S, Wu Y, Cai S, Pan Y, Liu W, Bian L . Over-expression of tetraspanin 8 in malignant glioma regulates tumor cell progression. Biochem Biophys Res Commun. 2015; 458(3):476-482. DOI: 10.1016/j.bbrc.2015.01.128. View

Jiang H, Liu W, Zhan S, Pan Y, Bian L, Sun B . GSK621 Targets Glioma Cells via Activating AMP-Activated Protein Kinase Signalings. PLoS One. 2016; 11(8):e0161017. PMC: 4988667. DOI: 10.1371/journal.pone.0161017. View

Park S, Choi J, Oh E, Kim Y, Park Y, Cho E . Clinical significance of CD151 overexpression in subtypes of invasive breast cancer. Br J Cancer. 2012; 106(5):923-30. PMC: 3306846. DOI: 10.1038/bjc.2012.11. View

Paiva B, Gutierrez N, Chen X, Vidriales M, Montalban M, Rosinol L . Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patients. Leukemia. 2012; 26(8):1862-9. DOI: 10.1038/leu.2012.42. View

Green D, Press O . Whither Radioimmunotherapy: To Be or Not To Be?. Cancer Res. 2017; 77(9):2191-2196. PMC: 5413412. DOI: 10.1158/0008-5472.CAN-16-2523. View

Lee M, Kim J, Lee J, Yun S, Kim W, Ahn H . Prognostic Significance of CREB-Binding Protein and CD81 Expression in Primary High Grade Non-Muscle Invasive Bladder Cancer: Identification of Novel Biomarkers for Bladder Cancer Using Antibody Microarray. PLoS One. 2015; 10(4):e0125405. PMC: 4411067. DOI: 10.1371/journal.pone.0125405. View

Szala S, Kasai Y, Steplewski Z, Rodeck U, KOPROWSKI H, Linnenbach A . Molecular cloning of cDNA for the human tumor-associated antigen CO-029 and identification of related transmembrane antigens. Proc Natl Acad Sci U S A. 1990; 87(17):6833-7. PMC: 54632. DOI: 10.1073/pnas.87.17.6833. View

Stuhlmiller G, Borowitz M, Seigler H . D6.1, a murine antimelanoma monoclonal antibody from congenitally athymic nude mice immunized with purified melanoma tumor-associated antigen. Hybridoma. 1984; 3(4):333-46. DOI: 10.1089/hyb.1984.3.333. View

Otsubo C, Otomo R, Miyazaki M, Matsushima-Hibiya Y, Kohno T, Iwakawa R . TSPAN2 is involved in cell invasion and motility during lung cancer progression. Cell Rep. 2014; 7(2):527-538. DOI: 10.1016/j.celrep.2014.03.027. View

10.

Voglstaetter M, Thomsen A, Nouvel J, Koch A, Jank P, Navarro E . Tspan8 is expressed in breast cancer and regulates E-cadherin/catenin signalling and metastasis accompanied by increased circulating extracellular vesicles. J Pathol. 2019; 248(4):421-437. PMC: 6771825. DOI: 10.1002/path.5281. View

11.

Zou Q, Xiong L, Yang Z, Lv F, Yang L, Miao X . Expression levels of HMGA2 and CD9 and its clinicopathological significances in the benign and malignant lesions of the gallbladder. World J Surg Oncol. 2012; 10:92. PMC: 3433354. DOI: 10.1186/1477-7819-10-92. View

12.

Agaesse G, Barbollat-Boutrand L, El Kharbili M, Berthier-Vergnes O, Masse I . p53 targets TSPAN8 to prevent invasion in melanoma cells. Oncogenesis. 2017; 6(4):e309. PMC: 5520488. DOI: 10.1038/oncsis.2017.11. View

13.

Bardelli A, Siena S . Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer. J Clin Oncol. 2010; 28(7):1254-61. DOI: 10.1200/JCO.2009.24.6116. View

14.

Anami K, Oue N, Noguchi T, Sakamoto N, Sentani K, Hayashi T . TSPAN8, identified by Escherichia coli ampicillin secretion trap, is associated with cell growth and invasion in gastric cancer. Gastric Cancer. 2015; 19(2):370-380. DOI: 10.1007/s10120-015-0478-z. View

15.

Kim T, Park C, Jeoung M, Lee W, Go N, Choi J . Generation of a human antibody that inhibits TSPAN8-mediated invasion of metastatic colorectal cancer cells. Biochem Biophys Res Commun. 2015; 468(4):774-80. DOI: 10.1016/j.bbrc.2015.11.031. View

16.

Uchida S, Shimada Y, Watanabe G, Li Z, Hong T, Miyake M . Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma. Br J Cancer. 1999; 79(7-8):1168-73. PMC: 2362236. DOI: 10.1038/sj.bjc.6690186. View

17.

Agaesse G, Barbollat-Boutrand L, Sulpice E, Bhajun R, El Kharbili M, Berthier-Vergnes O . A large-scale RNAi screen identifies LCMR1 as a critical regulator of Tspan8-mediated melanoma invasion. Oncogene. 2016; 36(4):446-457. DOI: 10.1038/onc.2016.219. View

18.

Friedl P, Wolf K . Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer. 2003; 3(5):362-74. DOI: 10.1038/nrc1075. View

19.

Park C, Kim T, Kim H, Kim Y, Jeoung M, Lee W . Therapeutic targeting of tetraspanin8 in epithelial ovarian cancer invasion and metastasis. Oncogene. 2016; 35(34):4540-8. DOI: 10.1038/onc.2015.520. View

20.

Guo Q, Xia B, Zhang F, Richardson M, Li M, Zhang J . Tetraspanin CO-029 inhibits colorectal cancer cell movement by deregulating cell-matrix and cell-cell adhesions. PLoS One. 2012; 7(6):e38464. PMC: 3367972. DOI: 10.1371/journal.pone.0038464. View